These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38060545)

  • 21. Lamotrigine for people with borderline personality disorder: a RCT.
    Crawford MJ; Sanatinia R; Barrett B; Cunningham G; Dale O; Ganguli P; Lawrence-Smith G; Leeson VC; Lemonsky F; Lykomitrou-Matthews G; Montgomery A; Morriss R; Munjiza J; Paton C; Skorodzien I; Singh V; Tan W; Tyrer P; Reilly JG
    Health Technol Assess; 2018 Apr; 22(17):1-68. PubMed ID: 29651981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol.
    McMain SF; Chapman AL; Kuo JR; Guimond T; Streiner DL; Dixon-Gordon KL; Isaranuwatchai W; Hoch JS
    BMC Psychiatry; 2018 Jul; 18(1):230. PubMed ID: 30016935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiating between intrapsychic symptoms and behavioral expressions of borderline personality disorder in relation to childhood emotional maltreatment and emotion dysregulation: an exploratory investigation.
    Goldbach RE; Neukel C; Panizza A; Reinken A; Krause-Utz A
    Eur J Psychotraumatol; 2023; 14(2):2263317. PubMed ID: 37846822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study.
    Amianto F; Ferrero A; Pierò A; Cairo E; Rocca G; Simonelli B; Fassina S; Abbate-Daga G; Fassino S
    BMC Psychiatry; 2011 Nov; 11():181. PubMed ID: 22103890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial.
    Juul S; Lunn S; Poulsen S; Sørensen P; Salimi M; Jakobsen JC; Bateman A; Simonsen S
    Trials; 2019 Apr; 20(1):196. PubMed ID: 30953536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot trial of moderated online social therapy for family and friends of young people with borderline personality disorder features.
    Gleeson J; Alvarez-Jimenez M; Betts JK; McCutcheon L; Jovev M; Lederman R; Herrman H; Cotton SM; Bendall S; McKechnie B; Burke E; Koval P; Smith J; D'Alfonso S; Mallawaarachchi S; Chanen AM
    Early Interv Psychiatry; 2021 Dec; 15(6):1564-1574. PubMed ID: 33260274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing three forms of early intervention for youth with borderline personality disorder (the MOBY study): study protocol for a randomised controlled trial.
    Chanen A; Jackson H; Cotton SM; Gleeson J; Davey CG; Betts J; Reid S; Thompson K; McCutcheon L
    Trials; 2015 Oct; 16():476. PubMed ID: 26489661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crisis interventions for adults with borderline personality disorder.
    Monk-Cunliffe J; Borschmann R; Monk A; O'Mahoney J; Henderson C; Phillips R; Gibb J; Moran P
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD009353. PubMed ID: 36161394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
    CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily Self-Monitoring of Symptoms and Skills Learning in Patients With Borderline Personality Disorder Through a Mobile Phone App: Protocol for a Pragmatic Randomized Controlled Trial.
    Helweg-Jørgensen S; Beck Lichtenstein M; Fruzzetti AE; Møller Dahl C; Pedersen SS
    JMIR Res Protoc; 2020 May; 9(5):e17737. PubMed ID: 32449690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder: A Randomized Clinical Trial (MBT-RCT).
    Juul S; Jakobsen JC; Hestbaek E; Jørgensen CK; Olsen MH; Rishede M; Frandsen FW; Bo S; Lunn S; Poulsen S; Sørensen P; Bateman A; Simonsen S
    Psychother Psychosom; 2023; 92(5):329-339. PubMed ID: 37935133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study Protocol for a randomized controlled trial of mentalization based therapy against specialist supportive clinical management in patients with both eating disorders and symptoms of borderline personality disorder.
    Robinson P; Barrett B; Bateman A; Hakeem A; Hellier J; Lemonsky F; Rutterford C; Schmidt U; Fonagy P
    BMC Psychiatry; 2014 Feb; 14():51. PubMed ID: 24555511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and cost-effectiveness of an experimental short-term inpatient Dialectical Behavior Therapy (DBT) program: study protocol for a randomized controlled trial.
    van den Bosch LM; Sinnaeve R; Hakkaart-van Roijen L; van Furth EF
    Trials; 2014 May; 15():152. PubMed ID: 24885551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Course of Borderline Personality Disorder.
    Stone MH
    Psychodyn Psychiatry; 2016; 44(3):449-74. PubMed ID: 27603806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial.
    Magni LR; Carcione A; Ferrari C; Semerari A; Riccardi I; Nicolo' G; Lanfredi M; Pedrini L; Cotelli M; Bocchio L; Pievani M; Gasparotti R; Rossi R;
    BMC Psychiatry; 2019 Jun; 19(1):195. PubMed ID: 31234864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BPD compass: A randomized controlled trial of a short-term, personality-based treatment for borderline personality disorder.
    Sauer-Zavala S; Southward MW; Fruhbauerova M; Semcho SA; Stumpp NE; Hood CO; Smith M; Elhusseini S; Cravens L
    Personal Disord; 2023 Sep; 14(5):534-544. PubMed ID: 36595435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological interventions for people with borderline personality disorder.
    Stoffers-Winterling JM; Storebø OJ; Pereira Ribeiro J; Kongerslev MT; Völlm BA; Mattivi JT; Faltinsen E; Todorovac A; Jørgensen MS; Callesen HE; Sales CP; Schaug JP; Simonsen E; Lieb K
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD012956. PubMed ID: 36375174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief psychiatric treatment for borderline personality disorder as a first step of care: Adapting general psychiatric management to a 10-session intervention.
    Kramer U; Kolly S; Charbon P; Ilagan GS; Choi-Kain LW
    Personal Disord; 2022 Sep; 13(5):516-526. PubMed ID: 34516155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responding to the treatment challenge of patients with severe BPD: results of three pilot studies of inpatient schema therapy.
    Reiss N; Lieb K; Arntz A; Shaw IA; Farrell J
    Behav Cogn Psychother; 2014 May; 42(3):355-67. PubMed ID: 23458343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Personality Disorders Institute/Borderline Personality Disorder Research Foundation randomized control trial for borderline personality disorder: rationale, methods, and patient characteristics.
    Clarkin JF; Levy KN; Lenzenweger MF; Kernberg OF
    J Pers Disord; 2004 Feb; 18(1):52-72. PubMed ID: 15061344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.